CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients: asciminib trial shows promise
Disease control OngoingThis study tests a drug called asciminib for people with chronic myeloid leukemia (CML) that has not responded well to other treatments, as well as for newly diagnosed patients. The goal is to see if the drug can reduce cancer cells to very low levels. Participants take asciminib…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
New drug combo aims to shield young transplant patients from dangerous immune attack
Disease control OngoingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children, adolescents, and young adults receiving a bone marrow or blood stem cell transplant for blood cancers or disorders. About 43 participants will receive vo…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:15 UTC